The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Health Canada has authorized Moderna's updated COVID-19 vaccine to roll out in fall immunization campaigns. The new Spikevax formula targets the KP.2 subvariant, one of the latest offshoots of the ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

Moderna said that the Canadian government has approved its updated Covid-19 Spikevax for individuals aged six months and older. The biotechnology company on Tuesday said that Health Canada authorized ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending.